Chapter 15. Antidepressants

  1. Stewart A. Factor DO1,
  2. Anthony E. Lang MD2 and
  3. William J. Weiner MD3
  1. Maria L. Moro-de-Casillas and
  2. David E. Riley

Published Online: 14 JAN 2008

DOI: 10.1002/9780470753217.ch15

Drug Induced Movement Disorders, Second Edition

Drug Induced Movement Disorders, Second Edition

How to Cite

Moro-de-Casillas, M. L. and Riley, D. E. (2005) Antidepressants, in Drug Induced Movement Disorders, Second Edition (eds S. A. Factor, A. E. Lang and W. J. Weiner), Blackwell Publishing Inc., Malden, Massachusetts, USA. doi: 10.1002/9780470753217.ch15

Editor Information

  1. 1

    Movement Disorders Center, Department of Neurology, Emory University, Atlanta, USA

  2. 2

    Movement Disorders Clinic, Toronto Western Hospital, Toronto, Canada

  3. 3

    Department of Neurology, University of Maryland School of Medicine, Baltimore, USA

Publication History

  1. Published Online: 14 JAN 2008
  2. Published Print: 1 JAN 2005

ISBN Information

Print ISBN: 9781405126199

Online ISBN: 9780470753217



  • antidepressants;
  • depression;
  • therapies;
  • electroconvulsive therapy;
  • drugs


This chapter contains section titled:

  • Introduction

  • Movement disorders induced by antidepressant therapy

  • Monoamine reuptake inhibitors

  • Monoamine oxidase (MAO) inhibitors

  • Electroconvulsive therapy

  • Lithium

  • Effects of antidepressant therapy on movement disorders

  • Parkinsonism

  • Myoclonus

  • Tremor

  • Tics and Tourette's syndrome

  • Dystonia

  • Tardive dyskinesia

  • Huntington's disease

  • Conclusion